Actual Medicinal Product (AMP) Ropinirole 2mg tablets (Viatris UK Healthcare Ltd)
Stability Information
- Stability
-
Medicines suitable for use in MCAs, although use is likely to be off-label. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or consider up to 8 weeks if the MCA is airtight (sealed). Consider the risk to the individual from potency loss or dose variability, particularly with unsealed devices. Monitor for any changes in therapeutic effect or increased adverse effects after MCA initiation.
- Notes
-
No special requirements for storage.
- Provenance
-
This compatibility recommendation is derived from ReQuip tablets (GlaxoSmithKline UK Ltd).
- Generic
- Ropinirole
- Formulation
- Ropinirole 2mg tablets
-
Ropinirole
-
Ropinirole 2mg tablets
-
Ropinirole 2mg tablets (Viatris UK Healthcare Ltd)
-
-
ReQuip 2mg tablets (GlaxoSmithKline UK Ltd)
Ropinirole 500microgram tablets